Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.8.0.1
Accrued Expenses
9 Months Ended
Sep. 30, 2017
Accrued Expenses  
Accrued Expenses

6. Accrued Expenses

 

Accrued expenses consist of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

    

September 30, 2017

    

December 31, 2016

 

External research and preclinical development

 

$

3,972

 

$

3,290

 

Employee compensation and benefits

 

 

2,116

 

 

1,911

 

Professional fees

 

 

850

 

 

819

 

Facilities

 

 

20

 

 

90

 

Restricted stock liability

 

 

 —

 

 

 5

 

 

 

$

6,958

 

$

6,115